Pharma Co. Chiasma To Settle Investors' IPO Suit For $18.7M
Biopharmaceutical company Chiasma and a proposed class of shareholders asked a Massachusetts judge for preliminary approval Friday of an $18.75 million settlement over claims the company misled prospective investors in its...To view the full article, register now.
Already a subscriber? Click here to view full article